🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the efficacy and safety of IBI112 ...
Status
Recruiting
Location
Beijing Children's Hospital Affiliated to Capital Medical University
Start Date
2025-12-03
Trial ID
NCT07265284
The purpose of this study is to evaluate the efficacy, safety, and tolerabi...
Status
Completed
Location
Shanghai Skin Disease Hospital
Start Date
2023-10-10
Trial ID
NCT06049810
Treatments Being Tested
This is a the first in human study to evaluate the safety, tolerability, PK...
Status
Completed
Location
Huashan Hospital Affiliated to Fudan University
Start Date
2020-08-27
Trial ID
NCT04511624
Treatments Being Tested
This is a multicenter, open-label study aim to evaluate the efficacy and sa...
Status
Completed
Location
Dermatology Hospital of Shandong First Medical University (Shandong Provincial Hospitial of Dermatology)
Start Date
2023-08-28
Trial ID
NCT05970978
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of IBI112 ...
Status
Completed
Location
Shanghai Skin Disease Hospital
Start Date
2023-02-10
Trial ID
NCT05645627
Treatments Being Tested
To evaluate the efficacy of IBI112 induction therapy in patients with moder...
Status
Completed
Location
First Affiliated Hospital of Sun Yat-sen University
Start Date
2022-07-01
Trial ID
NCT05377580
The purpose of this study is to evaluate the efficacy and safety of IBI112 ...
Status
Completed
Location
PeKing University People's Hostpital
Start Date
2021-09-23
Trial ID
NCT05003531
Treatments Being Tested